Acadia Pharma (ACAD) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $25.32 --0%
EPS Growth %: -62.5%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: -62.5%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.72), $0.01 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $15.29 million versus the consensus estimate of $15.19 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Canaccord
- Acadia Pharmaceuticals (ACAD) PT Raised to $37 at Deutsche Bank
- Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
